ERAS Erasca, Inc.: institutional ownership and insider trading
268 funds reported holding $5.44B of Erasca, Inc. in their latest 13F filings; in Q2 2026 funds net bought $306M, with 58 new positions and 28 funds selling out; over the last 12 months insiders bought $0 and sold $2.28M on the open market.
Famous investors holding ERAS
- Renaissance Technologies (Renaissance Technologies): $25.1M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $17.4M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $16.7M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $13.1M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $657K, 0.0% of the portfolio
Largest institutional holders of ERAS
- Frazier Life Sciences Management, L.P. — $458M
- T. Rowe Price Investment Management, Inc. — $388M
- BlackRock, Inc. (BLK) — $388M
- RTW INVESTMENTS, LP — $329M
- VR Adviser, LLC — $328M
- STATE STREET CORP (STT, STT-PG) — $223M
- Logos Global Management LP — $223M
- VANGUARD CAPITAL MANAGEMENT LLC — $209M
- Siren, L.L.C. — $209M
- Paradigm Biocapital Advisors LP — $175M
Recent ERAS insider trades
- Apr 1, 2026: Garner Ebun sold 80,000 shares ($1.31M)
- Mar 4, 2026: Morris Shannon sold 20,000 shares ($301K)
- Jan 7, 2026: Garner Ebun sold 120,000 shares ($671K)
5%+ owners
- Jonathan E. Lim: 10.4% (Schedule 13G/A, filed Aug 14, 2026)
- T. Rowe Price Investment Management, Inc.: 6.8% (Schedule 13G/A, filed May 15, 2026)
- Venrock Healthcare Capital Partners III, L.P.: 5.3% (Schedule 13G/A, filed May 15, 2026)
- RTW Investments, LP: 5.2% (Schedule 13G, filed May 15, 2026)